SCHEMBL457313

SCHEMBL457313

CC(C)NC(=S)NN=C1Nc2ccccc2C1=O

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.56
ALDH1A1 P00352 8/20 0.49
GAA P10253 6/20 0.49
ALOX12 P18054 3/20 0.49
MEN1 O00255 7/20 0.41
KMT2A Q03164 7/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
NPSR1 Q6W5P4 6/20 0.39
LMNA P02545 5/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
MAPT P10636 5/20 0.38
POLB P06746 1/20 0.38
HTT P42858 2/20 0.36
RAB9A P51151 1/20 0.36
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL455695 0.81 SLC2A1 (0.44) TDP1ALDH1A1GAAALOX12MEN1
SCHEMBL456344 0.79 KMT2A (0.50) TDP1ALDH1A1GAAMEN1KMT2A
SCHEMBL2877739 0.79 MAPT (0.51) TDP1ALDH1A1GAAALOX12MEN1
SCHEMBL458246 0.77 ALDH1A1 (0.49) TDP1ALDH1A1GAAALOX12MEN1
SCHEMBL455445 0.76 ALDH1A1 (0.42) TDP1ALDH1A1GAAMEN1KMT2A
SCHEMBL2877863 0.76 ALDH1A1 (0.46) ALDH1A1GAAMEN1KMT2ASMN1; SMN2
SCHEMBL455312 0.76 MAPT (0.42) TDP1ALDH1A1GAAALOX12MEN1
SCHEMBL457421 0.76 LRRK2 (0.42) TDP1ALDH1A1GAAALOX12MEN1
SCHEMBL455106 0.76 KMT2A (0.47) ALDH1A1GAAALOX12MEN1KMT2A
SCHEMBL455238 0.76 RAB9A (0.44) TDP1ALDH1A1GAASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033601-A1 THIOSEMICARBAZONES WITH MDR1 - INVERSE ACTIVITY THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2012-03-15 WO disclosed
EP-2240175-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services (US) 2010-10-20 EP disclosed
WO-2009102433-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-08-20 WO disclosed